These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21315221)

  • 41. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation　- An Optical Coherence Tomography Study.
    Jinnouchi H; Kuramitsu S; Shinozaki T; Tomoi Y; Hiromasa T; Kobayashi Y; Domei T; Soga Y; Hyodo M; Shirai S; Ando K
    Circ J; 2017 Mar; 81(4):450-457. PubMed ID: 28132981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison between optical coherence tomography and intravascular ultrasound in detecting neointimal healing patterns after stent implantation.
    Kochman J; Pietrasik A; Rdzanak A; Jąkała J; Zasada W; Scibisz A; Kołtowski L; Proniewska K; Pociask E; Legutko J
    Kardiol Pol; 2014; 72(6):534-40. PubMed ID: 24293141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal Neointimal Distribution Pattern After Everolimus-Eluting Stent Implantation: Insights From Optical Coherence Tomography Study.
    Curio J; Hioki H; Brugaletta S; Gomez-Lara J; Romaguera R; Cequier A; Herrera R; Jiménez-Quevedo P; Otsuki S; Masotti M; Sabaté M
    Cardiovasc Revasc Med; 2021 May; 26():17-23. PubMed ID: 33160894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging.
    Guagliumi G; Sirbu V; Musumeci G; Gerber R; Biondi-Zoccai G; Ikejima H; Ladich E; Lortkipanidze N; Matiashvili A; Valsecchi O; Virmani R; Stone GW
    JACC Cardiovasc Interv; 2012 Jan; 5(1):12-20. PubMed ID: 22230145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combined use of optical coherence tomography and intravascular ultrasound during percutaneous coronary intervention in patients with coronary artery disease].
    Hou JB; Meng LB; Jing SH; Han ZG; Yu H; Yu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):980-4. PubMed ID: 19102909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Sugi K
    J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K; Otsuji S; Yamamoto W; Takiuchi S; Ishibuchi K; Tamaru H; Kakishita M; Ibuki M; Hasegawa K; Ishii R; Nakabayashi S; Higashino Y
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):E398-E405. PubMed ID: 32077557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of tissue prolapse with optical coherence tomography and intravascular ultrasound after drug-eluting stent implantation.
    Sohn J; Hur SH; Kim IC; Cho YK; Park HS; Yoon HJ; Nam CW; Kim YN; Kim KB
    Int J Cardiovasc Imaging; 2015 Jan; 31(1):21-9. PubMed ID: 25273918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of luminal patency of the self-expanding Sideguard sidebranch stent: evaluation by intravascular ultrasound and optical coherence tomography.
    Ma S; Maehara A; Hauptmann KE; Guagliumi G; Valsecchi O; Vassileva AN; Appelman Y; Sangiorgi G; Prati F; Mintz GS
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):734-41. PubMed ID: 24948549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Qualitative and quantitative assessment of stent restenosis by optical coherence tomography: comparison between drug-eluting and bare-metal stents.
    Nagoshi R; Shinke T; Otake H; Shite J; Matsumoto D; Kawamori H; Nakagawa M; Kozuki A; Hariki H; Inoue T; Ohsue T; Taniguchi Y; Iwasaki M; Nishio R; Hiranuma N; Konishi A; Kinutani H; Miyoshi N; Takaya T; Yamada S; Yasaka Y; Hayashi T; Yokoyama M; Kato H; Kadotani M; Ohnishi Y; Hirata K
    Circ J; 2013; 77(3):652-60. PubMed ID: 23257388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessment of characteristics of neointimal hyperplasia after drug-eluting stent implantation in patients with diabetes mellitus: an optical coherence tomography analysis.
    Tian F; Chen Y; Liu H; Zhang T; Guo J; Jin Q
    Cardiology; 2014; 128(1):34-40. PubMed ID: 24514877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OCT analysis in patients with very late stent thrombosis.
    Kang SJ; Lee CW; Song H; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Mintz GS; Park SW; Park SJ
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):695-703. PubMed ID: 23643282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparisons of the effects of stent eccentricity on the neointimal hyperplasia between sirolimus-eluting stent versus paclitaxel-eluting stent.
    Kim BK; Ko YG; Oh S; Kim JS; Kang WC; Jeon DW; Yang JY; Choi D; Hong MK; Ahn T; Jang Y
    Yonsei Med J; 2010 Nov; 51(6):823-31. PubMed ID: 20879046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A newly formed and ruptured atheromatous plaque within neointima after drug-eluting stent implantation: 2-year follow-up intravascular ultrasound and optical coherence tomography studies.
    Oh CM; Moon J; Yu HT; Jang JY; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2011 Nov; 52(6):1028-30. PubMed ID: 22028171
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.